- Investopedia•4 hours ago
Gilead sold its GS-6637 drug and alcohol addiction medicine to Amygdala.
- TheStreet.com•6 hours ago
We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.
- Motley Fool•6 hours ago
Pitting gene-sequencing specialist Illumina against biotech Gilead Sciences to see which company is the better buy for long-term investors.
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||69.87 x 100|
|Ask||70.25 x 300|
|Day's Range||69.71 - 70.79|
|52 Week Range||65.38 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||7.03|
|Dividend & Yield||2.08 (2.98%)|
|1y Target Est||N/A|